TJPC(SH:600488) Zhi Tong Cai Jing·2025-11-04 07:44Core Viewpoint - Tianyao Pharmaceutical (600488.SH) announced that its subsidiary Tianyao Peace (Tianjin) Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration for the potassium hydrogen phosphate injection, which has passed the consistency evaluation of generic drug quality and efficacy [1] Group 1: Product Approval - The potassium hydrogen phosphate injection is a phosphorus supplement used to correct hypophosphatemia in adults and children when oral or enteral nutrition is not feasible, insufficient, or contraindicated [1] - The product is also indicated for parenteral nutrition in adults and children under similar conditions [1] Group 2: Research and Development - In July 2024, Tianyao Peace submitted a supplementary application for the consistency evaluation of the potassium hydrogen phosphate injection to the National Medical Products Administration, which has been accepted [1] - The cumulative R&D investment in the potassium hydrogen phosphate injection project by Tianyao Peace is approximately 9.21 million yuan [1]